Rheumatology International

, Volume 27, Issue 3, pp 225–233 | Cite as

Alpha-lipoic acid suppresses the development of collagen-induced arthritis and protects against bone destruction in mice

  • Eun Young Lee
  • Chang-Keun Lee
  • Ki-Up Lee
  • Joong Yeol Park
  • Kyung-Ja Cho
  • You Sook Cho
  • Hee Ran Lee
  • Se Hwan Moon
  • Hee-Bom Moon
  • Bin Yoo
Original Article

Abstract

Objective

To test the ability of alpha-lipoic acid (LA) to attenuate the development of collagen-induced arthritis (CIA) in mice.

Methods

Mice were divided into three groups and treated with intraperitoneal administration of LA (10 or 100 mg/kg) or placebo. Clinical, histologic, and biochemical parameters were assessed. Human synovial fibroblasts and peripheral blood mononuclear cells were cocultured in various concentrations of LA to evaluate the effects on osteoclastogenesis.

Results

LA was associated with a dose-dependent reduction of CIA, as well as preventing bone erosion and destructive changes. Intracellular reactive oxygen species in lymphocytes obtained from inguinal lymph nodes, which was significantly higher in CIA than control mice, was significantly reduced in CIA by LA. The concentrations of TNF-α, IL-1β, and IL-6 in the paws, and synovial NF-κB binding, all of which were markedly higher in CIA than control mice, were reduced by treatment with LA. In addition, LA inhibited the formation of human osteoclasts in vitro.

Conclusion

Amelioration of joint disease by LA was associated with reduction in oxidative stress, as well as inhibition of inflammatory cytokine activation and NF-κB DNA binding activity. Moreover, LA inhibited bone destruction in vivo and osteoclastogenesis in vitro. Collectively, these results indicate that LA may be a new adjunctive therapy for rheumatoid arthritis.

Keywords

Alpha-lipoic acid Rheumatoid arthritis Collagen-induced arthritis Reactive oxygen species NF-κB Osteoclast 

Notes

Acknowledgments

This work was supported by institutional grant from Asan Institute for Life Science (2003-330), Seoul, Korea. We thank S.K. Park and S.K. Lee (Division of Nephrology, Department of Internal Medicine, Asan Medical Center, Seoul, Korea) for the technical support on EMSA. We are grateful to J.R. Kim (Asan Institute for Life Science, Seoul, Korea) for animal care.

References

  1. 1.
    Sambrook PN, Spector TD, Seeman E, Bellamy N, Buchanan RR, Duffy DL, Martin NG, Prince R, Owen E, Silman AJ, et al (1995) Osteoporosis in rheumatoid arthritis. A monozygotic co-twin control study. Arthritis Rheum 38:806–809PubMedGoogle Scholar
  2. 2.
    Haugeberg G, Uhlig T, Falch JA, Halse JI, Kvien TK (2000) Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register. Arthritis Rheum 43:522–530PubMedCrossRefGoogle Scholar
  3. 3.
    Ozturk HS, Cimen MY, Cimen OB, Kacmaz M, Durak I (1999) Oxidant/antioxidant status of plasma samples from patients with rheumatoid arthritis. Rheumatol Int 19:35–37PubMedCrossRefGoogle Scholar
  4. 4.
    Cimen MY, Cimen OB, Kacmaz M, Ozturk HS, Yorgancioglu R, Durak I (2000) Oxidant/antioxidant status of the erythrocytes from patients with rheumatoid arthritis. Clin Rheumatol 19:275–277PubMedCrossRefGoogle Scholar
  5. 5.
    Taysi S, Polat F, Gul M, Sari RA, Bakan E (2002) Lipid peroxidation, some extracellular antioxidants, and antioxidant enzymes in serum of patients with rheumatoid arthritis. Rheumatol Int 21:200–204PubMedCrossRefGoogle Scholar
  6. 6.
    Heliovaara M, Knekt P, Aho K, Aaran RK, Alfthan G, Aromaa A (1994) Serum antioxidants and risk of rheumatoid arthritis. Ann Rheum Dis 53:51–53PubMedGoogle Scholar
  7. 7.
    Edmonds SE, Winyard PG, Guo R, Kidd B, Merry P, Langrish-Smith A, Hansen C, Ramm S, Blake DR (1997) Putative analgesic activity of repeated oral doses of vitamin E in the treatment of rheumatoid arthritis. Results of a prospective placebo controlled double blind trial. Ann Rheum Dis 56:649–655PubMedGoogle Scholar
  8. 8.
    Bandt MD, Grossin M, Driss F, Pincemail J, Babin-Chevaye C, Pasquier C (2002) Vitamin E uncouples joint destruction and clinical inflammation in a transgenic mouse model of rheumatoid arthritis. Arthritis Rheum 46:522–532PubMedCrossRefGoogle Scholar
  9. 9.
    Handelman GJ, Han D, Tritschler H, Packer L (1994) Alpha-lipoic acid reduction by mammalian cells to the dithiol form, and release into the culture medium. Biochem Pharmacol 47:1725–1730PubMedCrossRefGoogle Scholar
  10. 10.
    Suzuki YJ, Tsuchiya M, Packer L (1991) Thioctic acid and dihydrolipoic acid are novel antioxidants which interact with reactive oxygen species. Free Radic Res Commun 15:255–263PubMedGoogle Scholar
  11. 11.
    Scott BC, Aruoma OI, Evans PJ, O’Neill C, Van der Vliet A, Cross CE, Tritschler H, Halliwell B (1994) Lipoic and dihydrolipoic acids as antioxidants. A critical evaluation. Free Radic Res 20:119–133PubMedCrossRefGoogle Scholar
  12. 12.
    Nickander KK, McPhee BR, Low PA Tritschler H (1996) Alpha-lipoic acid: antioxidant potency against lipid peroxidation of neural tissues in vitro and implications for diabetic neuropathy. Free Radic Biol Med 21:631–639PubMedCrossRefGoogle Scholar
  13. 13.
    Constantinescu A, Han D, Packer L (1993) Vitamin E recycling in human erythrocyte membranes. J Biol Chem 268:10906–10913PubMedGoogle Scholar
  14. 14.
    Kikugawa K, Kato T, Beppu M, Hayasaka A (1991) Development of fluorescence and cross-links in eye lens crystallin by interaction with lipid peroxy radicals. Biochim Biophys Acta 1096:108–114PubMedGoogle Scholar
  15. 15.
    Ziegler D, Hanefeld M, Ruhnau KJ, Meissner HP, Lobisch M, Schutte K, Gries FA (1995) Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN study). Diabetologia 38:1425–1433PubMedCrossRefGoogle Scholar
  16. 16.
    Ziegler D, Schatz H, Conrad F, Gries FA, Ulrich H, Reichel G (1997) Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie. Diabetes Care 20:369–373PubMedGoogle Scholar
  17. 17.
    Apparailly F, Verwaerde C, Jacquet C, Auriault C, Sany J, Jorgensen C (1998) Adenovirus-mediated transfer of viral IL-10 gene inhibits murine collagen-induced arthritis. J Immunol 160:5213–5220PubMedGoogle Scholar
  18. 18.
    Williams RO, Feldmann M, Maini RN (1992) Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci USA 89:9784–9788PubMedCrossRefGoogle Scholar
  19. 19.
    Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254PubMedCrossRefGoogle Scholar
  20. 20.
    LeBel CP, Ischiropoulos H, Bondy SC (1992) Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 5:227–231PubMedCrossRefGoogle Scholar
  21. 21.
    Schreiber E, Matthias P, Muller MM, Schaffner W (1989) Rapid detection of octamer binding proteins with ‘mini-extracts’, prepared from a small number of cells. Nucleic Acids Res 17:6419PubMedCrossRefGoogle Scholar
  22. 22.
    Gerlag DM, Ransone L, Tak PP, Han Z, Palanki M, Barbosa MS, Boyle D, Manning AM, Firestein GS (2000) The effect of a T cell-specific NF-kappa B inhibitor on in vitro cytokine production and collagen-induced arthritis. J Immunol 165:1652–1658PubMedGoogle Scholar
  23. 23.
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedGoogle Scholar
  24. 24.
    Takayanagi H, Oda H, Yamamoto S, Kawaguchi H, Tanaka S, Nishikawa T, Koshihara Y (1997) A new mechanism of bone destruction in rheumatoid arthritis: synovial fibroblasts induce osteoclastogenesis. Biochem Biophys Res Commun 240:279–286PubMedCrossRefGoogle Scholar
  25. 25.
    Lee CK, Lee EY, Chung SM, Mun SH, Yoo B, Moon HB (2004) Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand. Arthritis Rheum 50:3831–3843PubMedCrossRefGoogle Scholar
  26. 26.
    Nagamatsu M, Nickander KK, Schmelzer JD, Raya A, Wittrock DA, Tritschler H, Low PA (1995) Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care 18:1160–1167PubMedGoogle Scholar
  27. 27.
    Marracci GH, Jones RE, McKeon GP, Bourdette DN (2002) Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis. J Neuroimmunol 131:104–114PubMedCrossRefGoogle Scholar
  28. 28.
    Miyazawa K, Mori A, Okudaira H (1999) IL-6 synthesis by rheumatoid synoviocytes is autonomously upregulated at the transcriptional level. J Allergy Clin Immunol 103:S437–S444PubMedCrossRefGoogle Scholar
  29. 29.
    Bondeson J, Foxwell B, Brennan F, Feldmann M (1999) Defining therapeutic targets by using adenovirus: blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators. Proc Natl Acad Sci USA 96:5668–5673PubMedCrossRefGoogle Scholar
  30. 30.
    Firestein GS, Boyle DL, Yu C, Paine MM, Whisenand TD, Zvaifler NJ, Arend WP (1994) Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis. Arthritis Rheum 37:644–652PubMedGoogle Scholar
  31. 31.
    Shin H, Kitajima I, Nakajima T, Shao Q, Tokioka T, Takasaki I, Hanyu N, Kubo T, Maruyama I (1999) Thrombin receptor mediated signals induce expressions of interleukin 6 and granulocyte colony stimulating factor via NF-kappa B activation in synovial fibroblasts. Ann Rheum Dis 58:55–60PubMedCrossRefGoogle Scholar
  32. 32.
    Aupperle KR, Bennett BL, Boyle DL, Tak PP, Manning AM, Firestein GS (1999) NF-kappa B regulation by I kappa B kinase in primary fibroblast-like synoviocytes. J Immunol 163:427–433PubMedGoogle Scholar
  33. 33.
    Choy EH, Panayi GS (2001) Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 344:907–916PubMedCrossRefGoogle Scholar
  34. 34.
    Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, Jackson CG, Lange M, Burge DJ (1999) A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 340:253–259PubMedCrossRefGoogle Scholar
  35. 35.
    Dinarello CA (2000) The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1. N Engl J Med 343:732–734PubMedCrossRefGoogle Scholar
  36. 36.
    Choy EH, Isenberg DA, Garrood T, Farrow S, Ioannou Y, Bird H, Cheung N, Williams B, Hazleman B, Price R, Yoshizaki K, Nishimoto N, Kishimoto T, Panayi GS (2002) Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Arthritis Rheum 46:3143–3150PubMedCrossRefGoogle Scholar
  37. 37.
    Nakamura I, Kadono Y, Takayanagi H, Jimi E, Miyazaki T, Oda H, Nakamura K, Tanaka S, Rodan GA, Duong le T (2002) IL-1 regulates cytoskeletal organization in osteoclasts via TNF receptor-associated factor 6/c-Src complex. J Immunol 168:5103–5109PubMedGoogle Scholar
  38. 38.
    Abramson SB, Amin A (2002) Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage. Rheumatology (Oxford) 41:972–980CrossRefGoogle Scholar
  39. 39.
    Kakimoto K, Kojima Y, Ishii K, Onoue K, Maeda H (1993) The suppressive effect of gelatin-conjugated superoxide dismutase on disease development and severity of collagen-induced arthritis in mice. Clin Exp Immunol 94:241–246PubMedCrossRefGoogle Scholar
  40. 40.
    Shingu M, Takahashi S, Ito M, Hamamatu N, Suenaga Y, Ichibangase Y, Nobunaga M (1994) Anti-inflammatory effects of recombinant human manganese superoxide dismutase on adjuvant arthritis in rats. Rheumatol Int 14:77–81PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Eun Young Lee
    • 1
  • Chang-Keun Lee
    • 1
  • Ki-Up Lee
    • 2
  • Joong Yeol Park
    • 2
  • Kyung-Ja Cho
    • 3
  • You Sook Cho
    • 1
  • Hee Ran Lee
    • 4
  • Se Hwan Moon
    • 4
  • Hee-Bom Moon
    • 1
  • Bin Yoo
    • 1
  1. 1.Division of Allergy and Rheumatology, Department of Internal MedicineUniversity of Ulsan College of Medicine, Asan Medical CenterSeoulRepublic of Korea
  2. 2.Division of Endocrinology, Department of Internal MedicineUniversity of Ulsan College of Medicine, Asan Medical CenterSeoulRepublic of Korea
  3. 3.Department of PathologyUniversity of Ulsan College of Medicine, Asan Medical CenterSeoulRepublic of Korea
  4. 4.Asan Institute for Life ScienceSeoulRepublic of Korea

Personalised recommendations